StockGlow

Sanofi (SNY)

Makes vaccines and medicines for diseases like cancer, inflammation, and infections.

$45.31+0.03%Healthcare
Compare SNY with
StockGlow Score
60
Leaning Bullish
BearishBullish
1 year ago-3.1%

The outlook

Sanofi trades at $45.31 with analyst consensus tilted toward Buy, and the average price target sits roughly 22% above current levels. The stock sits in the lower half of its 52-week range and shows mixed positioning against its moving averages. Overall sentiment leans bullish, though near-term momentum is modest.

What’s behind the score

Analyst consensusBuy — 2.0 avg of 9 analysts
Price trendMixed vs its moving averages
52-week range37% of the way from its 52-week low to high
Price targetAvg target +22% vs current price

Analyst price target

~12-month · 9 analysts
$55.06average target+21.5% vs now
Now $45.31
Low $49.00High $63.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
—
52-wk high
$52.68
52-wk low
$40.89
50-day avg
$43.44
200-day avg
$46.60
Trailing P/E
20.1

Similar stocks

GSKGSK plc$53.86+3.62%NVSNovartis AG$159.79+2.35%AZNAstraZeneca PLC$171.55+1.13%RHHBYRoche Holding AG$56.38+2.94%REGNRegeneron Pharmaceuticals, Inc.$690.31+3.47%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy